Menu

恩瑞格是哪产的?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is the first oral iron-removing agent approved by the U.S. FDA for routine use. It is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion. In Europe, it is recommended as a first-line drug for patients with thalassemia iron overload over 6 years old.

So, where did Enrig come from?

Manufacturer of Enriga: Novartis produces the original drug

Novartis, a multinational company in the global pharmaceutical and health industry, is one of the world's three largest pharmaceutical companies. It is headquartered in Basel, Switzerland, and has operations in more than 150 countries and regions around the world. Novartis has a diversified business portfolio covering innovative patented medicines, eye care, generic medicines, consumer health care and vaccines and diagnostics, and is a world leader in all fields.

Price of Enrig’s original medicine: one box is about $2,000. An average person weighing 60kg would spend more than $24,000 a month taking Desirox.

Manufacturer of Enrego: Cipla produces generic drugs

CIPLA (Cipla) is the second largest pharmaceutical company in India with strong financial and scientific research capabilities. Especially its cheap anti-AIDS and anti-cancer drugs are very popular among patients in developing countries.

Price of generic Enrig drugs: The specification of Desirox produced by Indian pharmaceutical factory is 500*30 tablets/box, and the price is about 500$. Due to the floating exchange rate, the price will be different. Please consult the medical companion for the specific price!

Instructions for using Enrig:

It needs to be done regularly every day, preferably at the same time. It needs to correspond to the weight of the body. It is initially recommended to take a dose of 20mg/kg per day. It depends on the serum ferritin index. If you need to increase the dose, you need to adjust it in 5mg/kg or 10mg/kg as the increasing unit. The maximum cannot exceed 30mg/kg.

It should be noted that it should be used according to the patient's comprehensive situation, such as illness, constitution, etc.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。